AzTrials
AzTrials

Developmental DyscalculiaNCT04242680

tRNS Combined to Cognitive Training in Children With Dyscalculia

A study testing Brainstim DLPFC, Brainstim PPC and Cognitive Training in people with Developmental Dyscalculia, run by Bambino Gesù Hospital and Research Institute at 1 site in Italy.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The present study grounds on the absence of evidence-based treatment in individuals with developmental dyscalculia (DD). At this topic, the present study will explore the potential effect of transcranial random noise stimulation (tRNS) over dorsolateral prefrontal cortex (DLPFC) or posterior parietal cortex (PPC)… Read more about this study

Who is it for?
Ages 8 to 14 years
Conditions the study is for
Developmental Dyscalculia
What is being tested?
Brainstim DLPFC, Brainstim PPC and Cognitive Training
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
102 participants
Where
1 siteItaly
Study dates
2 Sep 2019to 5 May 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 8 to 14 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Children and adolescents with DD (Total Quotient of BDE-2 ≤ 70)
  • IQ ≥ 85

Who cannot join

  • Having a comorbidity with an important medical conditions;
  • Having neurological diseases;
  • Having Epilepsy o family history of epilepsy;
  • Receiving a treatment for DD in the previous three months before the baseline screening;

Trial locations and contacts

1 site in 1 country.

Giulia Lazzaro contact

giulia.lazzaro@opbg.net

Italy1 site, 1 recruiting
  • Bambino Gesù Hospital and Research Institute

    Roma, 00165

    Chiara Mennini, 06-68592572, chiara.mennini@opbg.net

    Rita Alparone, 06-68592859, rita.alparone@opbg.net

    Recruiting

Other trials in Italy

About this study

Official title: Improving Math Deficits in Children With Dyscalculia by tRNS: a Randomized, Double-blind Study

The present study grounds on the absence of evidence-based treatment in individuals with developmental dyscalculia (DD). At this topic, the present study will explore the potential effect of transcranial random noise stimulation (tRNS) over dorsolateral prefrontal cortex (DLPFC) or posterior parietal cortex (PPC), cerebral areas usually disrupted in individuals with DD, in addition to a usual treatment such as cognitive training.

Therefore, the investigators hypothesized that active tRNS over DLPFC or PPC combined to cognitive training will boost math and math-related skills in children and adolescents with DD, modulating theta/beta ratio around stimulated cerebral network. On the contrary, sham tRNS (placebo) over DLPFC or PPC combined to cognitive training will not have significant effect in improving math skills. Further, both active and sham tRNS combined to cognitive training will be safe and well tolerated.

Read the detailed description

The study design is randomized stratified, double blind, placebo-controlled.

A group of children and adolescents with DD will be selected and randomly assigned to three different conditions: 1. tRNS over bilateral DLPFC + cognitive training (Brainstim DLPFC); 2. tRNS over bilateral PPC (Brainstim PPC) + cognitive training; 3. sham tRNS (bilateral DLPFC/bilateral PPC; Brainstim Sham) + cognitive training.

In this project, the investigators will work to understand whether a brain-based intervention, with the use of tRNS, combined to a usual treatment can improve the outcome of individual with DD.

The protocol will allow the investigators to:

  1. testing the critical role of two brain regions (DLPFC or PPC) usually involved in numerical abilities and disrupted in individuals with DD;
  2. examining the neural changes (using EEG recordings) due to cognitive training without tRNS (Brainstim Sham) and with tRNS (Brainstim DLPFC; Brainstim PPC);
  3. predicting training outcomes based on math-related skills;
  4. testing the critical role of neural markers at developmental ages using a closed-loop tRNS to improve learning and cognitive outcomes from the training;
  5. investigating the safety and tolerability of tRNS.

The investigator's overarching goal is to provide a scientific foundation for devising new rehabilitation strategies in DD.

Being tested
Brainstim DLPFC, Brainstim PPC, Brainstim Sham, Cognitive Training
Keywords
Children, Adolescents, tRNS, transcranial random noise stimulation, EEG, numerical abilities, neurodevelopmental disorders, non-invasive brain stimulation, transcranial electrical stimulation
Medical subject headings
Dyscalculia, Neurodevelopmental Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Brainstim DLPFCDevice

    Also called tRNS over bilateral DLPFC

    The active tRNS will be delivered to bilateral DLPFC for five consecutive days for two weeks for a total of ten days.

    tRNS will be delivered by a battery driven, random-noise current stimulator through a pair of saline-soaked sponge electrodes kept firm by elastic bands.

    The electrodes will be placed on the left and right DLPFC, F3 and F4 position according to the 10-20 international EEG system for electrode placement, while participants will receive a usual treatment (cognitive training).

    Stimulation intensity will be set at 0.75 milliampere (mA) (100-500 Hz), the duration of stimulation will be 20 min.

  • Brainstim PPCDevice

    Also called tRNS over bilateral PPC

    The active tRNS will be delivered to bilateral PPC for five consecutive days for two weeks for a total of ten days.

    tRNS will be delivered by a battery driven, random-noise current stimulator through a pair of saline-soaked sponge electrodes kept firm by elastic bands.

    The electrodes will be placed on the left and right PPC, P3 and P4 position according to the 10-20 international EEG system for electrode placement, while participants will receive a usual treatment (cognitive training).

    Stimulation intensity will be set at 0.75mA (100-500 Hz), the duration of stimulation will be 20 min.

  • Brainstim ShamDevice

    Also called Sham tRNS (bilateral DLPFC/bilateral PPC)

    The same electrode placement will be used as in the stimulation conditions (Brainstim DLPFC or Brainstim PPC), but the current will be applied for 30 s and will be ramped down without the participants awareness, and will be held five consecutive days for two weeks for a total of ten days.

  • Cognitive TrainingBehavioural

    A cognitive training (Vektor; Nemmi et al., 2016) will be adiministered concomitantly to Brainstim DLPFC, Brainstim PPC, Brainstim Sham for 20 min.

    The training consisted of math exercises (number line, calculations) and math-related exercises (visuo-spatial working memory, mental rotation).

Study groups in NCT04242680
Study groupRoleWhat they receive
Brainstim DLPFCExperimentaltRNS over bilateral DLPFC + cognitive training
Receives: Device: Brainstim DLPFC; Behavioral: Cognitive Training
Brainstim PPCExperimentaltRNS over bilateral PPC + cognitive training
Receives: Device: Brainstim PPC; Behavioral: Cognitive Training
Brainstim ShamSham comparatorSham tRNS (bilateral DLPFC/bilateral PPC) + cognitive training
Receives: Device: Brainstim Sham; Behavioral: Cognitive Training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number Line

    The proportion of patients with change of at least 1 SD in the "number line task" of the Diagnostic battery for Dyscalculia (BDE 2, Biancardi et al., 2016) in Brainstim DLPFC and Brainstim PPC than in Brainstim Sham.

    Measured: immediately after the intervention, one week and three months after the intervention

Secondary outcomes (17)
  1. Total Quotient

    The proportion of patients with change in the "Total Quotient" of the BDE 2 (Biancardi et al., 2016) in Brainstim DLPFC and Brainstim PPC than in Brainstim Sham.

    Measured: immediately after the intervention, one week and three months after the intervention

  2. Numerical Quotient

    The proportion of patients with change in the "Numerical Quotient" of the BDE 2 (Biancardi et al., 2016) in Brainstim DLPFC and Brainstim PPC than in Brainstim Sham.

    Measured: immediately after the intervention, one week and three months after the intervention

  3. Calculation Quotient

    The proportion of patients with change in the "Calculation Quotient" of the BDE 2 (Biancardi et al., 2016) in Brainstim DLPFC and Brainstim PPC than in Brainstim Sham.

    Measured: immediately after the intervention, one week and three months after the intervention

  4. Number Sense Quotient

    The proportion of patients with change in the "Number Sense Quotient" of the BDE 2 (Biancardi et al., 2016) in Brainstim DLPFC and Brainstim PPC than in Brainstim Sham.

    Measured: immediately after the intervention, one week and three months after the intervention

  5. Mental multiplications and additions

    The proportion of patients with change in the Mental Multiplications and Mental Additions tasks of the Diagnostic battery for Dyscalculia 1 (Biancardi et al., 2004) in Brainstim DLPFC and Brainstim PPC than in Brainstim Sham.

    Measured: immediately after the intervention, one week and three months after the intervention

  6. Tempo Test Rekenen

    The proportion of patients with change in the total scores of the Tempo Test Rekenen (De Vos, 1992) in Brainstim DLPFC and Brainstim PPC than in Brainstim Sham.

    Measured: immediately after the intervention, one week and three months after the intervention

  7. Geometric Puzzle

    The proportion of patients with change in the total scores of the Geometric Puzzle (Nepsy II, Korkman et al., 2011) in Brainstim DLPFC and Brainstim PPC than in Brainstim Sham.

    Measured: immediately after the intervention, one week and three months after the intervention

  8. Math computerized task

    The proportion of patients with change in a math computerized task (Math Proc, PEBL) in Brainstim DLPFC and Brainstim PPC than in Brainstim Sham.

    Measured: immediately after the intervention, one week and three months after the intervention

  9. Motivation and study strategies Questionnaire

    The proportion of patients with change (lower score means better outcome) in the Motivation and study strategies Questionnaire from 8 to 15 ages (AMOS 8-15, Cornoldi et al., 2005) in Brainstim DLPFC and Brainstim PPC than in Brainstim Sham.

    Measured: immediately after the intervention, one week and three months after the intervention

  10. Math Anxiety Questionnaire

    The proportion of patients with change (lower score means better outcome) in the Math Anxiety Questionnaire (MARS, Saccani and Cornoldi, 2005) in Brainstim DLPFC and Brainstim PPC than in Brainstim Sham.

    Measured: immediately after the intervention, one week and three months after the intervention

  11. Sleep quality

    The proportion of patients with change (lower score means better outcome) in the Sleep Disturbance Scale for Children (SDSC, Bruni et al., 1996) in Brainstim DLPFC and Brainstim PPC than in Brainstim Sham.

    Measured: immediately after the intervention, one week and three months after the intervention

  12. Parental stress

    The proportion of patients with change (higher score means better outcome) in the Parent Stress Index (PSI, Guarino et al., 2014) in Brainstim DLPFC and Brainstim PPC than in Brainstim Sham.

    Measured: immediately after the intervention, one week and three months after the intervention

  13. Emotional/behavioural problems

    The proportion of patients with change (lower score means better outcome) in the Cross-symptom assessment scales of the Kiddie-Sads- present and lifetime version-Diagnostic and Statistical Manual of Mental Disorders 5 (K-SADS- DSM-5, Kaufman et al., 2016) in Brainstim DLPFC and Brainstim PPC than in Brainstim Sham.

    Measured: immediately after the intervention, one week and three months after the intervention

  14. Math improvement at school

    The proportion of patients with change in math markers in the transcript (scale from 0 to 10, where 10 is the best level and 0 the worst) in Brainstim DLPFC and Brainstim PPC than in Brainstim Sham.

    Measured: three months after the intervention

  15. Theta/Beta ratio

    The proportion of patients with reduction of theta/beta ratio in Brainstim DLPFC and Brainstim PPC than in Brainstim Sham.

    Measured: immediately after the intervention, one week and three months after the intervention

  16. Verbal and visuo-spatial working-memory

    The proportion of patients with change in the index of verbal and visuo-spatial n-back (more score means better outcome) in Brainstim DLPFC and Brainstim PPC than in Brainstim Sham.

    Measured: immediately after the intervention, one week and three months after the intervention

  17. Incidence of Treatment-Emergent Adverse Events [Safety and tolerability]

    The proportion of patients with change in the questionnaire of safety and tolerability (Questionnaire of adverse effect; Brunoni et al., 2011) in Brainstim DLPFC and Brainstim PPC will be the same than in Brainstim Sham.

    Measured: immediately after the intervention, one week and three months after the intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Jan 2020
  2. Study start2 Sep 2019
  3. Primary completion5 Jan 2024 (estimated)
  4. Study completion5 May 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
102 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04242680
Sponsor's protocol ID
1547_OPBG_2018
Status last verified
Feb 2023
First submitted
15 Jan 2020
Last updated
10 Feb 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • APA (2013). Diagnostic and statistical manual of mental disorders: DSM 5. Washington, DC: American Psychiatric Association.

  • Baroody, AJ., Tiilikainen, SH. Two perspectives on addition development. In: Baroody AJ, Dowker A, editors. The development of arithmetic concepts and skills: The construction of adaptive expertise. Erlbaum; Mahwah, NJ: 2003. pp. 75-125.

  • Belacchi, C., Scalisi, T.G., Cannoni, E. e Cornoldi, C. (2008). Matrici Progressive di Raven Forma

  • Biancardi, A., Bachmann, C., Nicoletti, C. (2016) BDE 2 - Batteria discalculia evolutiva Test per la diagnosi dei disturbi dell'elaborazione numerica e del calcolo in età evolutiva - 8-13 anni.

  • Cornoldi, C., Colpo, G. (2012). Prove di Lettura MT per la Scuola Elementare-2, Firenze, Organizzazioni Speciali.

  • Lehto, J.E. et al. (2003). Dimensions of executive functioning: Evidence from children. British Journal of Developmental Psychology, 21, 59-80.

  • Sartori, G., Job, R., Tressoldi, PE. (2007). DDE-2. Batteria per la valutazione della dislessia e della disortografia evolutiva, Firenze, Organizzazioni Speciali.

  • Ambrus GG, Paulus W, Antal A. Cutaneous perception thresholds of electrical stimulation methods: comparison of tDCS and tRNS. Clin Neurophysiol. 2010 Nov;121(11):1908-14. doi: 10.1016/j.clinph.2010.04.020. Epub 2010 May 14.

    PubMed 20471313
  • Ansari D. Effects of development and enculturation on number representation in the brain. Nat Rev Neurosci. 2008 Apr;9(4):278-91. doi: 10.1038/nrn2334.

    PubMed 18334999
  • Arsalidou M, Taylor MJ. Is 2+2=4? Meta-analyses of brain areas needed for numbers and calculations. Neuroimage. 2011 Feb 1;54(3):2382-93. doi: 10.1016/j.neuroimage.2010.10.009. Epub 2010 Oct 12.

    PubMed 20946958
  • Butterworth B. Foundational numerical capacities and the origins of dyscalculia. Trends Cogn Sci. 2010 Dec;14(12):534-41. doi: 10.1016/j.tics.2010.09.007.

    PubMed 20971676
  • Butterworth B, Varma S, Laurillard D. Dyscalculia: from brain to education. Science. 2011 May 27;332(6033):1049-53. doi: 10.1126/science.1201536.

    PubMed 21617068
  • Cantlon JF, Brannon EM, Carter EJ, Pelphrey KA. Functional imaging of numerical processing in adults and 4-y-old children. PLoS Biol. 2006 May;4(5):e125. doi: 10.1371/journal.pbio.0040125. Epub 2006 Apr 11.

    PubMed 16594732
  • Cappelletti M, Gessaroli E, Hithersay R, Mitolo M, Didino D, Kanai R, Cohen Kadosh R, Walsh V. Transfer of cognitive training across magnitude dimensions achieved with concurrent brain stimulation of the parietal lobe. J Neurosci. 2013 Sep 11;33(37):14899-907. doi: 10.1523/JNEUROSCI.1692-13.2013.

    PubMed 24027289
  • Chaieb L, Antal A, Pisoni A, Saiote C, Opitz A, Ambrus GG, Focke N, Paulus W. Safety of 5 kHz tACS. Brain Stimul. 2014 Jan-Feb;7(1):92-6. doi: 10.1016/j.brs.2013.08.004. Epub 2013 Sep 13.

    PubMed 24064065

Questions about this trial

What is this clinical trial studying?

A study testing Brainstim DLPFC, Brainstim PPC and Cognitive Training in people with Developmental Dyscalculia, run by Bambino Gesù Hospital and Research Institute at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 10 Feb 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Deny Menghini (06.6859. 2875, deny.menghini@opbg.net), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number Line (time frame: immediately after the intervention, one week and three months after the intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04242680, which also lists 56 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Feb 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in